Combination of ofatumumab and reduced-dose CHOP for diffuse large B-cell lymphomas in patients aged 80 years or older: an open-label, multicentre, single-arm, phase 2 trial from the LYSA group

Frédéric Peyrade, Serge Bologna, Vincent Delwail, Jean‐François Emile, Laurent Pascal, Christophe Fermé, Bertrand Coiffier, Bernadette Corront, H. Farhat, Christophe Fruchart,

The Lancet Haematology · 2016 · 117 citations · 25 references

Concepts

References

25